Cargando…
PAX6 disease models for aniridia
Aniridia is a pan-ocular genetic developmental eye disorder characterized by complete or partial iris and foveal hypoplasia, for which there is no treatment currently. Progressive sight loss can arise from cataracts, glaucoma, and aniridia-related keratopathy, which can be managed conservatively or...
Autores principales: | Abdolkarimi, Dorsa, Cunha, Dulce Lima, Lahne1, Manuela, Moosajee, Mariya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940591/ https://www.ncbi.nlm.nih.gov/pubmed/36453299 http://dx.doi.org/10.4103/ijo.IJO_316_22 |
Ejemplares similares
-
Longitudinal genotype-phenotype analysis in 86 patients with PAX6-related aniridia
por: Kit, Vivienne, et al.
Publicado: (2021) -
Restoration of functional PAX6 in aniridia patient iPSC-derived ocular tissue models using repurposed nonsense suppression drugs
por: Lima Cunha, Dulce, et al.
Publicado: (2023) -
The Spectrum of PAX6 Mutations and Genotype-Phenotype Correlations in the Eye
por: Lima Cunha, Dulce, et al.
Publicado: (2019) -
Generation of human iPSC line (UCLi013-A) from a patient with microphthalmia and aniridia, carrying a heterozygous missense mutation c.372C>A p.(Asn124Lys) in PAX6
por: Harding, Philippa, et al.
Publicado: (2021) -
PAX6 aniridia and interhemispheric brain anomalies
por: Abouzeid, Hana, et al.
Publicado: (2009)